R&D Systems™ Recombinant Human S100A11 Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Supplier:  R&D Systems™ 9015S11050

Catalog No. 90-15S-11050

Description

The Recombinant Human S100A11 Protein is derived from E. coli. The Recombinant Human S100A11 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P31949
• Gene ID (Entrez): 6282
• Quantity: 50μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: calgizzarin, Metastatic lymph node gene 70 protein, MLN 70, MLN70, protein S100-A11, Protein S100-C, S100 calcium binding protein A11, S100 calcium-binding protein A11, S100 calcium-binding protein A11 (calgizzarin), S100C, S100CS100 calcium binding protein A11 (calgizzarin)
• Gene Symbol: S100A11
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining

• For Use With (Application): Bioactivity
• Molecular Weight (g/mol): Observed M.W.: 9kDa, reducing conditions, Theoretical M.W.: 12kDa
• Source: E. coli-derived human S100A11 protein Ala2-Thr105
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Common Name: S100A11
• Biological Activity: Measured by its binding ability in a functional ELISA. When Recombinant Human ANXA-2 is immobilized at 0.5μg/mL (100μL/well), the concentration of Recombinant Human S100A11 that produces 50% of the optimal binding response is approximately 0.4-2.4μg/mL.
• Species: Human
• Expression System: E. coli-derived Ala2-Thr105